Immunic to Participate in Investor and Scientific Conferences in August
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Source: prnewswire.com